Cognitive Strategies for Optimizing Brain Health And Managing Transgenerational Vascular Risk Factors Post-Stroke
University of New Mexico · NCT06479174
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 40
- US sites recruiting
- 1
- Study start
- October 12, 2023
- Record last updated
- October 9, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
People living with the cognitive effects of stroke are at risk for recurrent stroke and further cognitive decline. Also problematic is that stroke risk clusters in families and biological family members of people who have ischemic stroke may also be at increased risk of stroke and/or cognitive decline. The primary goal of this study is to test the feasibility of a virtually delivered cognitive strategy training and health coaching program to reduce vascular risk and promote brain health in persons with stroke and their biological family members.
Being studied: CHAMPS-TR
Conditions: Stroke, Ischemic
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- primary diagnosis of acute ischemic stroke,
- impairment of cognitive function (score >1 on Quick Executive Interview - telephone screener),
- absence of severe aphasia (score of 0 or 1 on NIH Stroke Scale),
- absence of pre-stroke dementia (client report),
- absence of major anxiety and depressive disorder (PHQ-9, GAD-7),
- absence of drug and alcohol misuse within 3 months of study (AUDIT, DAST),
- greater than 40 years of age,
- having a potential family member who meets targeted family member criteria,
- eligible for MRI and Remote Supervised-transcranial direct current stimulation (RS-tDCS) if in CHAMPS-TR plus RS-tDCS (e.g., not pregnant; no intracranial metal implants; no skin lesions on target sites for stimulation; no severe cardiopulmonary, renal or hepatic diseases; no pacemakers; no underlying medical reason for not engaging in MRI or tDCS).
The targeted family member will be
- a minimum of 18 years of age,
- biological kin of person with stroke,
- absence of dementia (client report),
- absence of major anxiety and depressive disorder (PHQ-9, GAD-7),
- absence of drug and alcohol misuse within 3 months of study (AUDIT, DAST),
- greater than 18 years of age, and
- having a sibling or parent who had an ischemic stroke
Exclusion Criteria
For all participants
- not English speaking, reading, and understanding, and
- no access to video-conference software on a computer or smart device
Recruiting US locations
University of New Mexico Health Sciences Center
Albuquerque, NM 87131
Site contact: Suzanne Burns, PhD
Study contacts (from the official record)
- Suzanne Burns, PhD · 5052723324 · scburns@salud.unm.edu
- Tim Dionne, PhD · 5052720639 · tdionne@salud.unm.edu
Similar studies in New Mexico
All neurology studies in New Mexico →- RecruitingPhase 3
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
Zenas BioPharma (USA), LLC
- Location
- Albuquerque, NM + 24 other US sites
- Eligibility basics
- Ages 18–60
- RecruitingPhase 3
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
Hoffmann-La Roche
- Location
- Albuquerque, NM + 67 other US sites
- Eligibility basics
- Ages 50–90
- RecruitingPhase 3
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Kallyope Inc.
- Location
- Albuquerque, NM + 111 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy
Vertex Pharmaceuticals Incorporated
- Location
- Albuquerque, NM + 57 other US sites
- Eligibility basics
- Ages 18–80